Common atrial flutter catheter ablation without discontinuing oral anticoagulation. (September 2017)

• Record Type: Journal Article
• Authors: Escobar, Carlos; Castrejón, Sergio; de Oca, Rosa Montes; Ortega, Marta; Lopez-Sendon, José Luis; Merino, José Luis
• Is Part Of: Future cardiology. Volume 13:Number 5(2017)
• Page Start: 429
• Page End: 432
• Publication Date: 2017-09
• Subjects: anticoagulation -- atrial flutter -- catheter ablation -- cavo-tricuspid isthmus; Cardiology -- Research -- Periodicals; 616.12005
• DOI: 10.2217/fca-2017-0007
• Languages: English
• ISSNs: 1479-6678

Abstract

Aim: To determine if performing catheter ablation under oral anticoagulation is associated with a higher risk of thromboembolic or bleeding complications.Methods: Patients with common atrial flutter that underwent catheter ablation of the cavo-tricuspid isthmus were consecutively included in the study. All patients were taking oral anticoagulants at least 3 weeks before the ablation.Results: A total of 102 patients (mean age 67.9 ± 10.3 years; 83.3% male) were included. Among them 80.6% patients were taking acenocoumarol, 10.7% dabigatran, 7.8% rivaroxaban and 0.9% apixaban. After the procedure, no new pericardial effusion or major complications were detected. In the study 7.8% of patients had mild hematoma in the puncture site.Conclusion: Performing common atrial flutter catheter ablation under oral anticoagulation is associated with low risk of complications.